Clinical Trial Update: Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on quizartinib in combination with standard chemotherapy and as continuation therapy for newly diagnosed FLT3-ITD-positive acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Acute Myeloid Leukemia, Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2022-10-05